Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s diseaseSimon Dujardin, Bradley T. Hyman, Pieter Beerepoot et al.|Nature Medicine|2020Cited by 445
Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neuronsC García Sánchez, Fiona Elwood, Christopher M. Acker et al.|Communications Biology|2021Cited by 30
The evolution of Alzheimer’s target identification: Towards a fusion of artificial and cellular intelligenceGayle Wittenberg, Simon Lovestone, Fiona Elwood et al.|The Journal of Prevention of Alzheimer s Disease|2025Cited by 0